Jones DR - Search Results

1

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.

Li BT, Michelini F, Misale S, Cocco E, Baldino L, Cai Y, Shifman S, Tu HY, Myers ML, Xu C, Mattar M, Khodos I, Little M, Qeriqi B, Weitsman G, Wilhem CJ, Lalani AS, Diala I, Freedman RA, Lin NU, Solit DB, Berger MF, Barber PR, Ng T, Offin M, Isbell JM, Jones DR, Yu HA, Thyparambil S, Liao WL, Bhalkikar A, Cecchi F, Hyman DM, Lewis JS, Buonocore DJ, Ho AL, Makker V, Reis-Filho JS, Razavi P, Arcila ME, Kris MG, Poirier JT, Shen R, Tsurutani J, Ulaner GA, de Stanchina E, Rosen N, Rudin CM, Scaltriti M. Li BT, et al. Among authors: jones dr. Cancer Discov. 2020 May;10(5):674-687. doi: 10.1158/2159-8290.CD-20-0215. Epub 2020 Mar 25. Cancer Discov. 2020. PMID: 32213539 Free PMC article.

2

Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation.

Isbell JM, Deppen S, Putnam JB Jr, Nesbitt JC, Lambright ES, Dawes A, Massion PP, Speroff T, Jones DR, Grogan EL. Isbell JM, et al. Among authors: jones dr. Ann Thorac Surg. 2011 Jan;91(1):227-33; discussion 233. doi: 10.1016/j.athoracsur.2010.08.054. Ann Thorac Surg. 2011. PMID: 21172518 Free PMC article.

3

Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging.

Taylor MD, LaPar DJ, Davis JP, Isbell JM, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. Among authors: jones dr. Ann Thorac Surg. 2013 Jul;96(1):225-30: discussion 230-1. doi: 10.1016/j.athoracsur.2013.01.074. Epub 2013 Apr 22. Ann Thorac Surg. 2013. PMID: 23618518

4

Leiomyoma presenting as a massive calcified circumferential esophageal mass.

Walters DM, Vaughn NH, Isbell JM, Jeffus SK, Atkins KA, Sauer BG, Jones DR. Walters DM, et al. Among authors: jones dr. Ann Thorac Surg. 2013 Nov;96(5):1851-4. doi: 10.1016/j.athoracsur.2013.01.097. Ann Thorac Surg. 2013. PMID: 24182472

5

Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.

Taylor MD, LaPar DJ, Isbell JM, Kozower BD, Lau CL, Jones DR. Taylor MD, et al. Among authors: jones dr. J Thorac Cardiovasc Surg. 2014 Feb;147(2):738-44; Discussion 744-6. doi: 10.1016/j.jtcvs.2013.09.064. Epub 2013 Nov 16. J Thorac Cardiovasc Surg. 2014. PMID: 24252944 Free article.

6

Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program.

Huang J, Logue AE, Ostroff JS, Park BJ, McCabe M, Jones DR, Bains MS, Rizk NP, Kris MG, Rusch VW. Huang J, et al. Among authors: jones dr. Ann Thorac Surg. 2014 Sep;98(3):955-61. doi: 10.1016/j.athoracsur.2014.05.020. Epub 2014 Jul 31. Ann Thorac Surg. 2014. PMID: 25087931 Free PMC article.

7

Predictors of early recurrence for node-negative t1 to t2b non-small cell lung cancer.

Kiankhooy A, Taylor MD, LaPar DJ, Isbell JM, Lau CL, Kozower BD, Jones DR. Kiankhooy A, et al. Among authors: jones dr. Ann Thorac Surg. 2014 Oct;98(4):1175-83. doi: 10.1016/j.athoracsur.2014.05.061. Epub 2014 Aug 16. Ann Thorac Surg. 2014. PMID: 25134863

8

Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.

Wamsley JJ, Kumar M, Allison DF, Clift SH, Holzknecht CM, Szymura SJ, Hoang SA, Xu X, Moskaluk CA, Jones DR, Bekiranov S, Mayo MW. Wamsley JJ, et al. Among authors: jones dr. Cancer Res. 2015 Jan 15;75(2):426-35. doi: 10.1158/0008-5472.CAN-13-2702. Epub 2014 Nov 28. Cancer Res. 2015. PMID: 25432175 Free PMC article.

9

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.

Ujiie H, Kadota K, Chaft JE, Buitrago D, Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, Jones DR, Adusumilli PS. Ujiie H, et al. Among authors: jones dr. J Clin Oncol. 2015 Sep 10;33(26):2877-84. doi: 10.1200/JCO.2015.60.9818. Epub 2015 Aug 10. J Clin Oncol. 2015. PMID: 26261257 Free PMC article.

10

Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.

Ziv E, Erinjeri JP, Yarmohammadi H, Boas FE, Petre EN, Gao S, Shady W, Sofocleous CT, Jones DR, Rudin CM, Solomon SB. Ziv E, et al. Among authors: jones dr. Radiology. 2017 Jan;282(1):251-258. doi: 10.1148/radiol.2016160003. Epub 2016 Jul 19. Radiology. 2017. PMID: 27440441 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,385 results

Search Page